AIkido Pharma Inc. (NASDAQ:AIKI – Get Free Report) shares passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $2.79 and traded as high as $6.25. AIkido Pharma shares last traded at $5.55, with a volume of 233,412 shares changing hands.
AIkido Pharma Stock Performance
The company has a market cap of $30.44 million, a PE ratio of -1.43 and a beta of 0.93. The stock’s 50-day simple moving average is $4.76 and its 200 day simple moving average is $2.79.
About AIkido Pharma
AIkido Pharma Inc, a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia.
Featured Stories
- Five stocks we like better than AIkido Pharma
- Upcoming IPO Stock Lockup Period, Explained
- 3 Undervalued Stocks You Can Buy at a Discount Now
- Canadian Penny Stocks: Can They Make You Rich?
- AMD Stock: Can the PC Refresh Cycle Spark a Rally?
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Micron Stock Spikes 7%—3 Key Catalysts Behind the Move
Receive News & Ratings for AIkido Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AIkido Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
